Organon (OGN) Change in Receivables (2020 - 2026)

Organon's Change in Receivables history runs 7 years deep, the most recent figure standing at $65.0 million for Q1 2026.

• In Q1 2026, Change in Receivables fell 23.53% year-over-year to $65.0 million; the TTM figure through Mar 2026 stood at -$99.0 million (up 26.67% YoY), while the FY2025 annual figure was -$79.0 million, up 79.37% from the prior year.
• Change in Receivables was $65.0 million for Q1 2026 at Organon, up from -$160.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $230.0 million in Q2 2023 to a low of -$341.0 million in Q4 2024.
• Historically, Change in Receivables has averaged -$3.6 million across 5 years, with a median of $4.0 million in 2022.
• Biggest YoY gain for Change in Receivables was 866.67% in 2024; the steepest drop was 1362.96% in 2024.
• A 5-year view of Change in Receivables shows it stood at $4.0 million in 2022, then surged by 575.0% to $27.0 million in 2023, then sank by 1362.96% to -$341.0 million in 2024, then surged by 53.08% to -$160.0 million in 2025, then surged by 140.62% to $65.0 million in 2026.
• The last three Change in Receivables figures came in at $65.0 million (Q1 2026), -$160.0 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.